Épron Quievy & Associé advised Paltech SAS within it’s second fundraising

After a first fundraising in 2021, Paltech SAS closed in October 2023 a new round of more than one million euros fully subscribed by private investors.
Founded by doctors Réginald Allouche and Charles-Henri Malbert in 2021, Paltech SAS is an innovative company dedicated to the research for a curative treatment for type 2 diabetes.
Type 2 diabetes is a developing disease that affects more than 800 million people worldwide. The complications induced by this disease both in medium and long terms are strongly disabling. Type 2 diabetes is notably the main cause in non-traumatic amputations, blindness, kidney failure and neuropathy. Most treatments currently available are palliative and allow individuals to live with the disease without curing it. Paltech is developing a medical device that under certain conditions might cure people with type 2 diabetes. The first experiments made it possible to validate the proof of concept. Clinical trials with human beings are planned to start in 2025.
Paltech SAS is assisted by Épron Quievy & Associés on a day-to-day basis with Étienne Épron, partner and Cassandra Gimbert, associate.
More info on Paltech http://www.paltech.fr
Latest news
Étienne Épron at the Annual Conference of Université Paris Dauphine
On March 13, 2025, at 6:45 PM, Étienne Épron, managing partner at EQA Avocats, will take part in the annual conference of the Master 212 program at Université Paris Dauphine, titled: “De-dollarization: Can the World Function Without the Dollar? BRICS and the Dollar: Challenging American Hegemony.” This event will bring together experts in finance, economics,… Continue reading Étienne Épron at the Annual Conference of Université Paris Dauphine
EQA is hiring a junior associate to join the team
Our firm is currently seeking to hire a junior / mid-level associate with relevant work experience in corporate law, mergers and acquisitions, and tax. Ideally, the candidate will show between 1 and 3 years of work experience and demonstrate a side but strong interest in litigation, particularly in proceedings before the courts of the European… Continue reading EQA is hiring a junior associate to join the team
Defeating Russia at all costs—even that of the rule of law?
Étienne Épron published a column in Causeur magazine on January 30, 2025. The full version in French can be accessed at this link.
Justin Nuta joins EQA
We are pleased to announce the addition of Justin Nuta to our Corporate Law, Mergers & Acquisitions, and Tax departments. A legal professional awaiting admission to the Paris Bar, Justin holds a Master’s degree in Business Law and a Magistère in Business Law (D.J.C.E.) from Université Paris II Panthéon-Assas, as well as an LL.M. from… Continue reading Justin Nuta joins EQA